[1]OKUDA K, OHNISHI K, KIMURA K, et al.Incidence of portal vein thrombosis in liver cirrhosis.An angiographic study in 708 patients[J].Gastroenterology, 1985, 89 (2) :279-286.
|
[2]OGREN M, BERGQVIST D, BJORCK M, et al.Portal vein thrombosis:prevalence, patient characteristics and lifetime risk:a population study based on 23, 796 consecutive autopsies[J].World J Gastroenterol, 2006, 12 (13) :2115-2119.
|
[3]AMITRANO L, GUARDASCIONE MA, BRANCACCIO V, et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J].J Hepatol, 2004, 40 (5) :736-741.
|
[4]ZOCCO MA, Di STASIO E, de CRISTOFARO R, et al.Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51 (4) :682-689.
|
[5]VALLA DC, RAUTOU PE.The coagulation system in patients with end-stage liver disease[J].Liver Int, 2015, 35 (Suppl 1) :139-144.
|
[6]NORTHUP PG, CALDWELL SH.Coagulation in liver disease:a guide for the clinician[J].Clin Gastroenterol Hepatol, 2013, 11 (9) :1064-1074.
|
[7]TRIPODI A, PRIMIGNANI M, CHANTARANGKUL V, et al.Thrombin generation in patients with cirrhosis:the role of platelets[J].Hepatology, 2006, 44 (2) :440-445.
|
[8]TRIPODI A, MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med, 2011, 365 (2) :147-156.
|
[9]VILLA E, CAMMA C, MARIETTA M, et al.Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis[J].Gastroenterology, 2012, 143 (5) :1253-1260, e1251-e1254.
|
[10]TRIPODI A, ANSTEE QM, SOGAARD KK, et al.Hypercoagulability in cirrhosis:causes and consequences[J].J Thromb Haemost, 2011, 9 (9) :1713-1723.
|
[11]LIN JN, CHEN HJ, LIN MC, et al.Risk of venous thromboembolism in patients with splenic injury and splenectomy.A nationwide cohort study[J].Thromb Haemost, 2015, 115 (1) :176-183.
|
[12]KINJO N, KAWANAKA H, AKAHOSHI T, et al.Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension[J].Brit J Surg, 2010, 97 (6) :910-916.
|
[13]ROMANO F, CAPROTTI R, CONTI M, et al.Thrombosis of the splenoportal axis after splenectomy[J].Langenbecks Arch Surg, 2006, 391 (5) :483-488.
|
[14]JIANG GQ, BAI DS, CHEN P, et al.Laparoscopic splenectomy and azygoportal disconnection:a systematic review[J].Jsls, 2015, 19 (4) :e2015.
|
[15]ZAJA F, BARCELLINI W, CANTONI S, et al.Thrombopietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy.Results of a retrospective, observational GIMEMA study[J].Am J Hematol, 2016, 91 (5) :e293-e295.
|
[16]BOYER TD, HABIB S.Big spleens and hypersplenism:fix it or forget it?[J].Liver Int, 2015, 35 (5) :1492-1498.
|
[17]YERDEL MA, GUNSON B, MIRZA D, et al.Portal vein thrombosis in adults undergoing liver transplantation:risk factors, screening, management, and outcome[J].Transplantation, 2000, 69 (9) :1873-1881.
|
[18]QI X, HAN G, FAN D.Management of portal vein thrombosis in liver cirrhosis[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (7) :435-446.
|
[19]DELGADO MG, SEIJO S, YEPES I, et al.Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis[J].Clin Gastroenterol Hepatol, 2012, 10 (7) :776-783.
|
[20]LUCA A, MIRAGLIA R, CARUSO S, et al.Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis[J].Gut, 2011, 60 (6) :846-852.
|